July 28, 2017 12:03 PM ET


Company Overview of NEXTherapeutics, Inc.

Company Overview

NEXTherapeutics Inc. researches and develops antibody immunotherapy and diagnostic drugs for the treatment of oncology, hematology, infection, and inflammation diseases. The company’s products include NXT 211, a radio labeled antibody for treating refractory Hodgkin's disease; and Anti-Ferritin antibody coupled with Isotope 111 Indium for detecting cancerous tissue and treating cancer diseases. The company was incorporated in 2000 and is based in Cambridge, Massachusetts.

Riverside Technology Center

840 Memorial Drive

Cambridge, MA 02139

United States

Founded in 2000

Key Executives for NEXTherapeutics, Inc.

Chairman and Co-Founder
Age: 58
Chief Financial Officer
Vice President of Development and Regulatory Affairs
Executive Director of Clinical and Medical Affairs
Vice President of Scientific Partnerships
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NEXTherapeutics, Inc., please visit www.nextherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.